Recall Register

Food, drugs, devices › Smith & Nephew, Inc.

Device recall: TANDEM (TM) COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71322040, 71322041, 71322042, 71322043, 71322044, 71322045, 71

FDA enforcement event 75283 · Class II · initiated 29 Aug 2016 · status Terminated · terminated 16 Aug 2019

DeviceVoluntary: Firm initiated2 product recordsMemphis, TN

Smith & Nephew, Inc. (Memphis, TN) initiated this device recall on 29 Aug 2016; FDA lists 2 product records under event 75283, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,232 device enforcement events initiated in 2016 carry the same class.

Status: Terminated, terminated 16 Aug 2019. Initiation: voluntary: firm initiated. Smith & Nephew, Inc. has 107 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Smith & Nephew, Inc., Memphis, TN.

Reason for recall

"Some Bipolar shells were manufactured with an out of specification retainer groove."

Distribution

"Nationwide and Australia, Belgium, Canada, China, Cyprus, France, Germany, India, Italy, Japan, Korea, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0350-2017TANDEM (TM) COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71322040, 71322041, 71322042, 71322043, 71322044, 71322045, 71322046, 71322047, 71322048, 71322049, 71322050, 71322051, 71322052, 71322053, 71322054, 71322055, 713220572352 unitsClass IITerminated9 Nov 2016
Z-0351-2017TANDEM (TM) INTL COCR SHELL UHMWPE LINER BIPOLAR, REF NUMBERS: 71324038, 71324039, 71324040, 71324041, 71324042, 71324043, 71324044, 71324045, 71324046, 71324047, 71324048, 71324049, 71324050, 71324051, 71324052, 71324053, 71324054, 71324055, 71324057, 71324059, 71325039, 71325040, 71325041,71325042, 71325043,…5806 unitsClass IITerminated9 Nov 2016

Context

91%of 2016 device events are Class II1,232 events that year
2product records in this eventfirm median: 1
107events on this register for the firm

Other enforcement events for Smith & Nephew, Inc.

InitiatedProduct (first record)TypeClassRecords
16 Mar 2026TRIGEN PROXIMAL STRAIGHT HUMERAL NAIL 8/7 X 16, REF: 71760816DeviceClass II1
24 Nov 2025BIOSURE HA SCREW, 6MM x 20 MM. Threaded metallic bone fixation fastener.DeviceClass II1
18 Mar 2025META-TAN LAG/COMPRESSION SCREW KIT 90MM/85MM, REF: 71642690DeviceClass II1
29 Oct 2024BIORAPTOR Suture Anchors. Tendon/ligament, non-bioabsorbable bone anchor.DeviceClass II1
15 Oct 2024Tandem Intl Bipolar Cocr Shell/UHMWPE Liner, TI-6AL-4V Retaining Ring, 28MM I.D. 46 MM O.D., REF 71324046, sterile, femoDeviceClass II1
2 Oct 2024smith&nephew LEIGON OXINIUM CONSTRAINED NONPOROUS FEMORAL COMPONENT, SIZE 3 LEFT, REF 71421163; PROSTHESIS, KNEE, PATELLDeviceClass II2
2 Oct 2024smith&nephew GENESIS II NONPOROUS POSTERIOR STABILIZED FEMORAL COMPONENT, SIZE 5 LEFT, REF 71421015; Uncoated knee femurDeviceClass II2
12 Aug 2024ROTATION MEDICAL TENDON STAPLES (8) (broad indication)-Intended for fixation of prosthetic material to soft tissues. ProDeviceClass II2
9 Jul 2024DIAMOND POINT, BOTH ENDS K-WIRE, REF 128042, metallic bone fixation fastenerDeviceClass II2
24 Apr 2024smith&nephew OXINIUM Femoral Head 12/14 Taper, REF 71343204, 32 MM OD +4, Sterile; and smith&nephew, 12/14 Taper, REF 71DeviceClass II1

All 107 events for Smith & Nephew, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Some Bipolar shells were manufactured with an out of specification retainer groove."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide and Australia, Belgium, Canada, China, Cyprus, France, Germany, India, Italy, Japan, Korea, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 16 Aug 2019. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.